Editing Eating disorder (section)

===Medication===
[[Orlistat]] is used in obesity treatment. [[Olanzapine]] seems to promote weight gain as well as the ability to ameliorate obsessional behaviors concerning weight gain. [[zinc]] supplements have been shown to be helpful, and [[cortisol]] is also being investigated.<ref>{{cite journal |vauthors=Casper RC |title=How useful are pharmacological treatments in eating disorders? |journal=Psychopharmacology Bulletin |volume=36 |issue=2 |pages=88–104 |year=2002 |pmid=12397843}}</ref><ref>{{cite journal |vauthors=Goldberg SC, Halmi KA, Eckert ED, Casper RC, Davis JM |title=Cyproheptadine in anorexia nervosa |journal=The British Journal of Psychiatry |volume=134 |pages=67–70 |date=January 1979 |pmid=367480 |doi=10.1192/bjp.134.1.67 |s2cid=34037162}}</ref><ref>{{cite journal |vauthors=Walsh BT, Wilson GT, Loeb KL, Devlin MJ, Pike KM, Roose SP, Fleiss J, Waternaux C |title=Medication and psychotherapy in the treatment of bulimia nervosa |journal=The American Journal of Psychiatry |volume=154 |issue=4 |pages=523–31 |date=April 1997 |pmid=9090340 |doi=10.1176/ajp.154.4.523}}</ref><ref>{{cite journal |vauthors=Marrazzi MA, Markham KM, Kinzie J, Luby ED |title=Binge eating disorder: response to naltrexone |journal=International Journal of Obesity and Related Metabolic Disorders |volume=19 |issue=2 |pages=143–5 |date=February 1995 |pmid=7735342}}</ref><ref>{{cite journal |vauthors=Vandereycken W, Pierloot R |title=Pimozide combined with behavior therapy in the short-term treatment of anorexia nervosa. A double-blind placebo-controlled cross-over study |journal=Acta Psychiatrica Scandinavica |volume=66 |issue=6 |pages=445–50 |date=December 1982 |pmid=6758492 |doi=10.1111/j.1600-0447.1982.tb04501.x |s2cid=24384947}}</ref><ref>{{cite journal |vauthors=Birmingham CL, Gritzner S |title=How does zinc supplementation benefit anorexia nervosa? |journal=Eating and Weight Disorders |volume=11 |issue=4 |pages=e109-11 |date=December 2006 |pmid=17272939 |doi=10.1007/BF03327573 |s2cid=32958871}}</ref>

Two pharmaceuticals, Prozac<ref>{{Cite web |title=Treating bulimia nervosa |website=Harvard Health |url=https://www.health.harvard.edu/newsletter_article/Treating-bulimia-nervosa |access-date=2020-08-19 |url-status=dead |archive-date=2020-09-02 |archive-url=https://web.archive.org/web/20200902111941/https://www.health.harvard.edu/newsletter_article/Treating-bulimia-nervosa}}</ref> and Vyvanse,<ref>{{cite journal |vauthors=Guerdjikova AI, Mori N, Casuto LS, McElroy SL |title=Novel pharmacologic treatment in acute binge eating disorder - role of lisdexamfetamine |journal=Neuropsychiatric Disease and Treatment |volume=12 |pages=833–41 |date=2016-04-18 |pmid=27143885 |pmc=4841437 |doi=10.2147/NDT.S80881 |doi-access=free}}</ref> have been approved by the FDA to treat bulimia nervosa and binge-eating disorder, respectively. Olanzapine has also been used off-label to treat anorexia nervosa.<ref>{{Cite web | vauthors = Spettigue W |title=How much do we really know about the effectiveness of olanzapine use in patients with anorexia nervosa? |url=http://www.jneuropsychiatry.org/peer-review/how-much-do-we-really-know-about-the-effectiveness-of-olanzapine-use-in-patients-with-anorexia-nervosa-neuropsychiatry.pdf}}</ref> Studies are also underway to explore psychedelic and psychedelic-adjacent medicines such as MDMA, psilocybin and ketamine for anorexia nervosa and binge-eating disorder.<ref>{{Cite web |vauthors=Hampton J |date=2020-08-19 |title=What Psychedelics Could Mean for Eating Disorders |url=https://www.lucid.news/eating-disorders-psychedelic-therapy/ |access-date=2020-08-19 |website=Lucid News}}</ref>